Aqueous root extract of Dicoma anomala Sond ameliorates isoproterenol–induced myocardial infarction in Wistar rats by Balogun, Fatai O. & Ashafa, Anofi O.T.
Balogun & Ashafa 
Trop J Pharm Res, August 2016; 15(8): 1651  
 
Tropical Journal of Pharmaceutical Research August 2016; 15 (8): 1651-1657 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v15i8.8 
Original Research Article 
 
 
Aqueous root extract of Dicoma anomala Sond ameliorates 
isoproterenol–induced myocardial infarction in Wistar rats 
 
Fatai O Balogun and Anofi OT Ashafa* 
Phytomedicine and Phytopharmacology Research Group, Department of Plant Sciences, University of the Free State, Qwaqwa 
Campus, Private Bag x13, Phuthaditjhaba 9866, South Africa 
 
*For correspondence: Email: ashafaaot@ufs.ac.za; Tel: +27766757599 
 
Received: 16 April 2016        Revised accepted: 13 July 2016 
 
Abstract 
Purpose: To evaluate the protective potentials of the aqueous root extract of Dicoma anomala 
(AQRED) against isoproterenol (ISP)-induced myocardial damage in Wistar rats. 
Methods: Myocardial damage was induced in Wistar rats by isoproterenol (60 mg/kg body weight, b.w.) 
Various concentrations (125, 250, and 500 mg/kg b.w.) of AQRED and their effects on the rats’ feed and 
water intake, body weight changes, serum enzymes, including aspartate transaminase (AST), alanine 
transaminase (ALT) creatinine phosphokinase (CPK), as well as tissue antioxidant enzymes, including 
catalase (CAT), glutathione peroxidase (GP) and lipid peroxidation, during a 30-day experimental period 
were examined. 
Results: ISP-treated rats showed no significant (p > 0.05) effect on the feed, water and body weight but 
increased significantly (p < 0.05) AST, ALT, CPK and lipid peroxidation while significantly reducing CAT 
and GP levels (p < 0.05). Treatment with different doses of AQRED significantly (p < 0.05) reversed the 
activity of these enzymes and cardiac lipid peroxidation towards control levels. Histopathological 
examination of ISP-induced myocardial rats treated with D. anomala revealed evidence of oedema and 
myocardial necrosis at 125 and 250 mg/kg b.w. doses, but these alterations were ameliorated or 
cleared at 500 mg/kg dose, suggesting attainment of maximum efficacy. 
Conclusion: The findings indicate the ameliorative potential of AQRED in myocardiac disease, and 
therefore, could be of therapeutic significance in the management or treatment of cardiac-related 
diseases. 
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Myocardial infarction (MI), the most dreaded 
among the various forms of ischemic heart 
disease is the leading cause of morbidity and 
mortality in developed countries [1]. It is a 
condition of acute necrosis of the myocardium 
arising from the imbalance between the coronary 
blood supply and myocardial demand [2]. This is 
mostly followed by numerous pathophysiological 
and biochemical changes such as lipid 
peroxidation, thrombosis and hyperlipidemia [3], 
leading to myocardium alteration. MI preceding 
the development of heart failure is reported to be 
due to antioxidant deficit and increased 
myocardial oxidative stress. Hence, prompt 
intervention with an antioxidant may be of benefit 
against cardiac damage [4]. In recent times, due 
to adverse effects from synthetic drugs, interest 
in conventional medicines of natural sources 
have continued to increase particularly in 
developed and developing countries such as 
China, United States of America. [1,5]. The use 
of herbal therapies against numerous diseases 
Balogun & Ashafa 
Trop J Pharm Res, August 2016; 15(8): 1652  
 
including MI has been encouraged with few 
people doubting the effectiveness of the 
treatment modality [6]. 
 
Isoproterenol (ISP) is a synthetic catecholamine 
and a β-adrenergic agonist that causes severe 
stress in the myocardium, leading to an ‘infarct-
like’ necrosis of the heart muscles [3]. ISP forms 
free radicals and stimulates lipid peroxidation 
which perhaps cause irreversible damage to the 
myocardial membrane [6]. Thus, a high 
production of reactive oxygen species (ROS) 
may be a unifying mechanism in ischemic injury 
progression and antioxidants administration may 
protect against ISP induced cardiac damage. ISP 
induced myocardial injury is a well-established 
model used to study the beneficial effect of 
arrays of drugs on cardiac dysfunction [7,8]. This 
is because the pathophysiological signs in 
animals after ISP administration are similar to 
myofibrillar degeneration, a typical symptom of 
MI in humans [9]. 
 
South Africa is noted for her rich biodiversity in 
indigenous plants and she account for 9 % of the 
higher plants globally [10]. There are has been a 
continued interest in the development of 
therapeutic efficacies of medicinal plants in the 
treatment of numerous ailments. Besides being 
readily available, affordable and with minimal 
adverse effect, the presence of flavonoids, 
vitamins and polyphenols in these plants gave 
credence to their therapeutic significance and is 
well buttressed by the WHO [11]. 
 
Dicoma anomala (Asteraceae) commonly called 
fever or stomach bush (English) or hloenya 
(South Sotho) is a prostrate, decumbent or erect 
perennial herb with underground tuber. D. 
anomala is widely distributed in sub-Sahara 
Africa including South Africa within North West, 
Gauteng, Mpumalanga, Free State, Northern 
Cape and KwaZulu- Natal Provinces [12]. 
Traditionally, the plant is indicated in the 
treatment of various diseases such as coughs, 
cold, fever, ulcers, dermatosis and venereal 
ailments linked to numerous pharmacological 
activities including antiplasmodial, antibacterial, 
anthelmintic, antiviral and anti-inflammatory [13]. 
Previous studies on the plant revealed the 
antibacterial, anti-inflammatory and antioxidant 
activity of the root extracts [13] but little or no 
information has been reported on its 
cardioprotective or ameliorative efficacies. In this 
paper, we present the report on the ameliorative 
potential of aqueous root extract of D. anomala in 






Isoproterenol hydrochloride (ISP), assay kits 
such as alanine transaminase (ALT), aspartate 
transaminase (AST), creatine phosphokinase 
(CPK) were purchased from Sigma-Aldrich 
(South Africa). While water used was glass-
distilled, other chemicals and reagents used 
were of analytical grades. 
 
Plant collection and extraction 
 
Fresh rootstocks of D. anomala were collected 
from the wild within Phuthaditjhaba area of 
QwaQwa, Maluti- A - Phofung municipality of the 
Free State Province, South Africa in April 2014. 
The identity of this taxon was confirmed by Dr. 
AOT Ashafa of the Department of Plant 
Sciences, UFS, QwaQwa campus and the 
voucher specimen was deposited in the 
herbarium of University of Free State, South 
Africa. A total of 5.2 kg of fresh rootstock was 
washed, oven dried (40 °C) and ground with a 
hammer mill to yield 3.063 kg fine powdered 
plant material. Of this, 200 g was extracted with 2 
litres distilled water, filtered and concentrated on 
a water bath to yield 48.87 g of brown gummy 





Male and female Wistar rats (weighing 150 - 200 
g) were used in this study. They were procured 
from the animal facility of the University of the 
Free State, Bloemfontein. The animals were 
acclimatized for one week and maintained at (18 
± 2 °C under 12 h dark/light cycle. They were fed 
with standard rat feed (Epol mice cubes, 
Westville, South Africa) and water ad libitum. The 
husks in the cages were renewed thrice weekly 
to ensure proper hygiene and maximum comfort 
for animals. Ethical clearance for the animal 
studies was obtained from Institutional 
Interfaculty Animal Ethics Committee of the 
University of the Free State (no NR 02/13), prior 
to the commencement of the study in line with 
the internationally accepted guidelines of 
National Research Council for animal care and 




The animals were randomly divided into six 
groups of 6 rats each. Group A animals served 
as normal control and were orally administered 1 
mL normal saline for 30 days. The rats in Groups 
B, C, D, E and F were respectively treated with 1 
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mL normal saline, simvastatin (30 mg/kg b.w.) 
and 125, 250 and 500 mg/kg b.w. aqueous 
extract of D. anomala for 30 days via oral 
intubation. The rats in all the groups except 
group A were given ISP (60 mg/kg b.w.) [15], 
intraperitoneally on the first day of the 
experiment prior to administration of test drugs 
and the extracts. 
 
At the end of the experimental period, all the rats 
were anaesthetized with halothane and blood 
was collected from the retro-orbital plexus. About 
5 mL of the blood collected into a non-
heparinized bottle was centrifuged at 1285 g for 
10 min and the resulting serum was used for 
marker enzymes determination. The heart tissue 
was excised immediately and divided into two 
portions; a portion was immediately fixed in 10 % 
formalin for histopathological studies while the 
other portion was homogenized in ice-cold 0.1 
mol/L Tris-HCl buffer (pH 7.2). The supernatant 
obtained was used for the antioxidant assays as 
well as tissue activities of catalase (CAT), 
glutathione peroxidase (GP) and the level of lipid 
peroxidation in terms of thiobarbituric acid 
reactive species (TBARS) was estimated. The 
daily measurement of food intake and water 
consumption was recorded. 
  
Assessment of biochemical parameters 
 
The activities of ALT, AST, and CPK in the 
serum were determined following the procedures 
described in the Sigma-Aldrich assay kits.  
 
Determination of antioxidant parameters  
 
Glutathione peroxidase activity in tissues was 
assayed according to the method of Nicholas 
[16] while catalase activity determined based on 
the adapted method of Aebi [17]. Lipid 
peroxidation assayed by the formation of 
thiobarbituric acid reactive substances according 




A portion of the heart tissue from each group was 
fixed immediately in 10 % neutral formalin for a 
period of at least 24 h, dehydrated in graded (50 
– 100 %) alcohol, embedded in liquid paraffin, 
cut into 4-5 μm thick sections and stained with 
hematoxylin-eosin. The sections were evaluated 
and photographed for the pathological/ 
rejuvenative changes in the myocardial tissue 
under a canon power shot S72 digital camera (x 




Data analysis were done by one-way analysis of 
variance (ANOVA), followed by Bonferroni’s 
multiple comparison test and results are 
expressed as mean ± SEM using Graph Pad 
Prism version 3.0 for Windows software, Graph 
Pad software, San Diego, California, USA. 





Effect of AQRED on feed and water intake 
 
The effects of oral administration of AQRED on 
feed and water intake is presented in Table 1. 
ISP had no effect on feed and water intake of the 
experimental rats when compared with control. A 
significant (p < 0.05) increase in average feed 
and water intake of the cardiotoxic group with a 
similar increase in food and water consumption 
in all the treatment groups on days 10, 20 and 30 
was observed. 
 
Effect of AQRED on body weight changes 
 
Table 2 presents the effect of AQRED on 
average body weight changes of the 
experimental rats. As observed from the results, 
administration of ISP had no significant (p > 
0.05) effect on the weight of the animals treated 
with different doses of AQRED and simvastatin 
when compared with control group. 
 
Effect of AQRED on serum enzymes 
 
The effect of AQRED on serum enzymes of ISP-
induced cardiac damage is presented in Table 3. 
ISP showed no effect on the activity of ALT when 
compared with control. However, the ISP -
mediated increased serum activities of AST, 
ALT, and CPK were significantly (p < 0.05) and 
dose-dependently attenuated following 
treatments with simvastatin and the extracts 
although, simvastatin tends to restore the 
activities of these enzymes better towards 
normal than the extracts except in AST 
 
Effect of AQRED on tissue antioxidant status 
 
Table 4 shows the effects of AQRED on tissue 
marker enzymes. ISP significantly (p < 0.05) 
decreased the activities of the antioxidant marker 
enzymes (catalase and glutathione peroxidase) 
while It increased the level of TBARS when 
compared with control. Simvastatin and the three 
concentrations of the plant extract significantly (p 
< 0.05) increased the activities of the enzymes
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Figure 1: Photomicrograph showing: (A) normal heart architecture in control group (H&E 150x); (B) extensive 
tissue granulation, myocardial necrosis and coronary congestion (H&E 150x); (C) normal cardiomyocytes with 
mild oedema (H&E 150x); (D) myocardial necrosis and severe oedema (H&E 150x); (E) myofibres disintegration 
and oedema (H&E 150 x); (F) normal cardiomyocytes (H&E 150x). Figures are representative of four 
independent experiments  
 
Table 1: Effect of AQRED on feed and water intake of ISP -induced myocardial infarcted rats 
  
Parameters Control Isoproterenol Simvastatin 125 mg/kg 250 mg/kg 500 mg/kg 
AFI (g) Day 1- 10 148.90 ± 3.36a 150.90  ± 9.61a 137.94  ± 8.48a 113.70 ± 7.07a 122.34 ± 8.92a 116.78  ± 7.95a 
AFI (g) Day 11-20 148.50 ± 1.62a 167.02  ± 8.54b 178.06 ± 5.71b 137.72 ± 5.60b 157.32 ± 5.15b 147.06  ± 3.99b 
AFI (g) Day 21- 30 148.14  ± 1.98a 181.84  ± 5.13c 169.40  ± 4.93c 154.56 ± 1.91c 160.50 ± 3.53b 159.92 ± 1.56c 
AWI (ml) Day 1 -10 166.26 ± 4.45a 140.76 ± 5.89a 155.00 ± 5.55a 138.50 ± 11.54a 148.50 ± 9.01a 146.50 ± 8.25a 
AWI (ml) Day 11-20 171.20 ± 4.97b 146.00 ± 6.45b 164.80 ± 3.73b 162.20 ± 11.32b 169.00 ± 7.03b 168.00 ± 7.36b 
AWI (ml) Day 21- 30 179.20 ± 5.97c 167.80 ± 4.54c 171.80  ± 1.60c 173.60 ± 5.45c 189.40 ± 4.32c 194.80  ± 8.43c 
*Values with different superscript along the same column for each parameter are significantly (p < 0.05) to each 
other Key: AFI: Average feed intake; AWI: Average water intake 
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Table 2: Effect of AQRED on body weight of ISP -induced myocardial infarcted rats 
 
Parameters Control Isoproterenol Simvastatin 125 mg/kg 250 mg/kg 500 mg/kg 
Initial weight (g) 141.80 ± 10.55a 141.90 ± 5.94a 142.60 ± 11.52a 140.80 ± 9.52a 144.10 ± 9.53a 139.70 ± 6.64a 
ABW (g) Day 1– 10 172.80 ± 12.84a 168.70 ± 8.51a 169.20 ± 14.92a 164.00 ± 12.63a 162.30 ± 8.37a 165.90 ± 10.82a 
ABW (g) Day 11 – 20 185.70 ± 14.64a 179.20 ± 12.57a 180.10 ± 16.10a 170.30 ± 8.60b 174.30 ± 10.34a 175.40 ± 12.89b 
ABW (g) Day 21 – 30 200.80 ± 16.50a 194.10 ± 15.90a 194.10 ± 18.67a 187.80 ± 13.59b 192.70 ± 12.76a 192.40 ± 15.69a 
*Values with different superscript along the same row for each parameter are significantly different (p < 0.05) to 
each other; Key: ABW: Average body weight 
 
Table 3: Effect of AQRED on cardiac marker enzymes of ISP -induced myocardial infarcted rats  
 






ALT IU/L 12.96 ± 
2.40a 






AST IU/L 211 ± 
1.16a 


















Values are presented as mean ± SEM (n = 6). *Values with different superscript along the same row for each 
parameter are significantly different (p < 0.05); ALT: Alanine transaminase; AST: Aspartate transaminase; CPK: 
Creatine phosphokinase 
 
Table 4: Effect of AQRED on tissue marker enzymes of ISP-induced myocardial infarcted rats 
 




































Values are presented as mean ± SEM (n = 6). *Values with different superscript along the same row for each 
parameter are significantly different (p < 0.05). TBARS: Thiobarbituric acid reactive substances 
 
while they reduced TBARS level in a dose-
related manner by bringing towards normal the 
cardiac damage done to the rats. 
 
Effect of AQRED on histopathological 
alterations 
 
The result of histopathological examination of the 
heart sections from control and cardiotoxic rats is 
shown in Figure 1. Control rats showed normal 
cardiomyocytes with no visible lesions (Figure 
1A). The ISP-treated rats revealed necrotic 
cardiomyocytes, marked granulation of tissue 
characterized by collagenous tissue deposition 
and presence of coronary congestion (Figure 
1B). Simvastatin-treated rats exhibited normal 
cardiomyocytes with mild oedema (Fig 1C). 
Treatment with 125 mg/kg AQRED shows 
multiple areas of myofibres disintegration, 
presence of necrotic myocytes and severe 
oedema (Figure 1D). 250 mg/kg AQRED 
revealed myofibres disintegration and severe 
oedema (Figure 1E). However, at 500 mg/kg 





Destruction of myocardial cells arising from 
myocardial ischemia results in ruptured or 
damaged cardiac membrane thus, leading to 
leakage of heart enzymes [19]. MI occurs when 
there is an insufficient oxygen supply or glucose 
to the heart resulting in necrosis of the 
myocardium. CPK and LDH are marker enzymes 
diagnostically used to measure the level of 
cardiac damage and the release of these 
enzymes from the myocardial tissues of the heart 
into the bloodstream is an indication of 
myocardial damage induced by ISP. This does 
not only increase their concentration in the blood 
[20] but causes increase in heart rate, abnormal 
electrocardiogram (ECG) pattern [21,22] due to 
the formation of reactive oxygen species which 
ultimately leads to tissue degenerative changes 
resulting in the necrosis of the myocardium. The 
pathogenesis of MI has not been fully elucidated 
but insight into studies involving ISP-induced 
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cardiotoxicity suggests oxidative stress 
involvement. Moreover, increase in the serum 
activities of AST and ALT might also be 
attributed to myocardial injury [19]. 
 
The results of our study revealed increased 
activities of AST, ALT, and CPK following 
intraperitoneal administration of ISP, this affirms 
the preliminary prevalence of myocardial 
necrosis [23] and the leakage of marker enzymes 
from the heart to the blood. The treatment with 
different doses of AQRED reduced the level of 
these enzymes compared to control; this 
suggests the protective action of the plant in 
ameliorating cardiac damage arising from ISP. 
This result corroborates the previous report of 
Suchalatha and Shyamala-Devi [3] for Arogh as 
well as Sunmonu and Afolayan [24] for A. afra. 
 
Free radical formation and accumulation of lipid 
peroxides have been established as one of the 
probable biochemical mechanisms leading to 
myocardial damage from catecholamine such as 
ISP [25]. Catecholamine undergoes rapid 
oxidation and the oxidation products cause the 
necrosis of the cell and contractile failure in the 
rat heart [7]. CAT, superoxide dismutase, and 
GP are free radical scavenging enzymes 
concerned foremost with cellular defence against 
oxidative damage, O2 and H2O2 decomposition 
prior their interaction to form more reactive 
hydroxyl radical. It is, therefore, essential that 
equilibrium is maintained among these enzymes 
for effective removal of oxidative stress within 
intracellular organelles. It has been reported that 
glutathione protect the myocardium from free 
radical-induced injury and reduction in cellular 
glutathione content could hinder the recovery of 
ischemia after a short period [19]. The results 
from the present study indicate that treatment 
with doses of AQRED increased the level of 
catalase and glutathione peroxidase suggesting 
an improved antioxidant status in the system. 
The result of our study was in line with the 
submission of Raju et al [26] who reported a 
reduction in the activity of tissue antioxidant 
enzymes in rats with myocardial damage. 
 
Tissue damages are caused by free radicals; 
these free radicals attack the cellular membrane 
of the poly-unsaturated fatty acids (PUFAs) 
thereby causing lipid peroxidation [27]. 
Myocardial damage induced by ISP in rats 
causes lipid peroxidation and this signifies an 
elevated free radical generation [28]. The results 
of the present study reveal that rats treated with 
ISP show a significant increase in TBARS when 
compared with control group. Treatment with 
different doses of aqueous root extract of D. 
anomala reduced the elevated TBARS level. 
Histopathological analysis of the heart of ISP-
induced myocardial disease in rats treated with 
AQRED revealed the normal structure of the 
heart with some traces of oedema and necrotic 
myocytes when compared with the heart of ISP-
treated rats. This shows effective protection of 
AQRED most especially at the highest dose of 





The findings of this study indicate the 
ameliorative activity of AQRED in rats with 
myocardial disease. Thus, D. anomala might is a 
potential alternative source of medicine for the 
management and prevention of cardiovascular 
disease. Further studies are, however, required 
to identify the active components of the plant as 
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